Lumira raises $220-million for Canadian biotech fund

Lumira Logo.png

Lumira Ventures has raised the largest Canadian life sciences venture capital fund in two decades, drawing US$220-million from investors. But Lumira managing general partner Peter van der Velden called out Canada's pension plans outside of Quebec for failing to back the Toronto firm's fourth venture fund, or the teeming domestic life sciences sector as a whole.

Previous
Previous

It's Time for a Clinical Review of How We Support Biomedical Discoveries

Next
Next

Turnstone Biologics Raises $80 Million Series D Financing